By Hamza Faisal

Quest Diagnostics, one of the largest medical laboratory operators in the United States, has disclosed a cybersecurity breach that may have exposed patient records. In a regulatory filing with the Securities and Exchange Commission, the company said it learned on Oct 21 that an unauthorized party had gained access to its Quanum Lab Services Manager system, the platform some clients use to place test orders and to receive and look up results.

The company says it believes "certain patient records" were accessed, though it has not said how many people are affected, what type of information was exposed, or how the attackers got in. The full scope of the intrusion remains under investigation, and no group has publicly claimed responsibility.

What Quest has confirmed so far

According to the Oct 22 filing, Quest detected the unauthorized access on Oct 21, immediately started its cybersecurity incident response procedures, notified federal law enforcement authorities, and brought in external cybersecurity experts. It temporarily paused access to the Quanum system and said it is working toward "full restoration" as soon as possible.

Providers who order tests through direct-customer laboratory interfaces or their own electronic medical records systems can carry on as before, because those channels were not affected. Quest stressed that the incident has not materially disrupted its business operations and that core services remain up and running.

Healthcare keeps getting hit

The disclosure adds Quest to a growing list of medical and medtech companies targeted this year. Reuters has reported recent cyberattacks on device makers including Abbott, Stryker, Medtronic, and Boston Scientific, as hackers increasingly go after the health sector's troves of sensitive personal data.

Quest itself knows this pain: in 2019, personal information of about 11.9 million of its patients was impacted after a breach at American Medical Collection Agency, a billing collections vendor. The company has not yet said whether it will provide credit and identity monitoring to those affected by this latest incident.

Investors flinch despite a beat

The breach landed on the same day Quest reported third-quarter earnings: revenue of $3.10 billion, ahead of the $3.05 billion analysts expected. Even so, shares fell about 3.7% in premarket trading as investors weighed the security disclosure.

Quest said it will notify affected patients as required by law once its investigation identifies the specific data involved. Until then, patients who have had lab work done may want to treat unexpected messages about test results with suspicion. By Hamza Faisal